PET/CT is being increasingly recognized as a valuable tool in managing differentiated thyroid cancer, particularly in detecting recurrent or metastatic disease in patients with non-iodine-avid tumours or elevated Tg levels. The gene discussed is TG; the disease is metastatic neoplasm.